Effect of chitosan molecular weight and deacetylation degree on hemostasis
β Scribed by Jian Yang; Feng Tian; Zheng Wang; Qing Wang; Yan-Jun Zeng; Shi-Qian Chen
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 187 KB
- Volume
- 84B
- Category
- Article
- ISSN
- 1552-4973
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Comparative studies have been carried out among solidβstate chitosan soliquoid, chitosan acetic acid physiological saline solution, and carboxymethyl chitosan physiological saline solution to discover the hemostatic effect of molecular weight (M~w~) and deacetylation degree (DA) of chitosan. It was found that solidβstate chitosan and chitosan acetic acid physiological saline solution performed different hemostatic mechanisms. When blood mixed with chitosan acetic acid physiological saline solution, the erythrocytes aggregated and were deformed. The DA, especially a low DA, in the chitosan acetic acid physiological saline solution, had a significant effect on the unusual aggregation and deformation of erythrocytes, compared with the effect of M~w~ within a range between 10^5^ and 10^6^. However, this phenomenon could not be observed in solidβstate chitosan soliquoid. Solidβstate chitosan with a low DA absorbed more platelets and was more hemostatic. Carboxymethyl chitosan physiological saline solution had nothing to do with the aggregation and deformation of erythrocytes but caused local rouleau. The values of thrombin time (TT), prothrombin time (PT), activated partial thromboplastin time (APTT), and fibrinogen concentration (FIB) were measured after the blood was mixed with solidβstate chitosan soliquoid, chitosan acetic acid physiological saline solution, and carboxymethyl chitosan physiological saline solution, separately. The results demonstrated that coagulation factors might not be activated by them. Β© 2007 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 2008
π SIMILAR VOLUMES
## Abstract The aim of this study was to evaluate the potential of carboxymethyl chitosan (CMβchitosan) nanoparticles as carriers for the anticancer drug, doxorubicin (DOX). Different kinds of CMβchitosan with various molecular weight (MW) and degree of substitution (DS) were employed to prepare na